These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1435844)

  • 21. Nurses and emesis induced by cancer therapy.
    Dulfer S
    Nurs RSA; 1991 Mar; 6(3):9-11, 14. PubMed ID: 2046739
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanisms and management of nausea and emesis.
    Dicato M
    Oncology; 1996 Jun; 53 Suppl 1():1-3. PubMed ID: 8692544
    [No Abstract]   [Full Text] [Related]  

  • 23. [Development of a Japanese version of the FLIE].
    Satou A; Yamazaki T; Nukariya N; Nakamachi M; Shimada K; Matsukawa M; Kurihara M
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):281-91. PubMed ID: 11865635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A randomized trial of Zudan in the prophylaxis of nausea and vomiting induced by cisplatin].
    Huang J; Wang Z; Zhou L
    Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):153-4. PubMed ID: 10920971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of chemotherapy-related nausea and vomiting using a serotonin antagonist.
    Egan AP; Taggart JR; Bender CM
    Oncol Nurs Forum; 1992 Jun; 19(5):791-5. PubMed ID: 1535124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overview: oral granisetron (Kytril tablets) prophylaxis for chemotherapy-induced nausea and vomiting.
    Perez EA
    Semin Oncol; 1995 Aug; 22(4 Suppl 10):1-2. PubMed ID: 7570049
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of ondansetron, a 5-HT3 receptor antagonist, as a new type of antiemetic in pediatric oncology].
    Csáki C; Ferencz T; Koós R; Schuler D; Borsi J
    Orv Hetil; 1993 Jun; 134(25):1363-7. PubMed ID: 8332356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of emesis by tropisetron (Navoban) in children receiving cytotoxic therapy for solid malignancies.
    Otten J; Hachimi-Idrissi S; Balduck N; Maurus R
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):17-9. PubMed ID: 9113122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experience with the clinical use of navoban].
    Voznyĭ EK; Dobrovol'skaia NI; Volkova LA
    Vopr Onkol; 1995; 41(1):70-1. PubMed ID: 7667947
    [No Abstract]   [Full Text] [Related]  

  • 32. The symptomatic control of cytostatic drug-induced emesis. A recent history and review.
    Joss RA; Brand BC; Buser KS; Cerny T
    Eur J Cancer; 1990; 26 Suppl 1():S2-8. PubMed ID: 2169781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The problem of delayed emesis after cancer chemotherapy: a possible new treatment.
    Hasler WL
    Gastroenterology; 1999 Sep; 117(3):737-8. PubMed ID: 10464153
    [No Abstract]   [Full Text] [Related]  

  • 34. Ondansetron to prevent vomiting after cancer chemotherapy.
    Med Lett Drugs Ther; 1991 Jun; 33(847):63-4. PubMed ID: 1828531
    [No Abstract]   [Full Text] [Related]  

  • 35. Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?
    de Wit R; Aapro M; Blower PR
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):231-8. PubMed ID: 15838653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on the management of chemotherapy-related nausea and vomiting: an emphasis on the new class of agents--neurokinin-1 receptor antagonists.
    Gralla R
    Clin Adv Hematol Oncol; 2006 Jul; 4(7):507-8. PubMed ID: 17147235
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical evaluation of granisetron (BRL43694) in nausea and vomiting induced by anticancer drugs--pediatrics].
    Sawada T; Matsumura T; Mugishima H; Kaneko M; Ohira M; Sugimoto T; Onuma N; Sakurai M; Takeda T
    Gan To Kagaku Ryoho; 1999 Aug; 26(9):1295-304. PubMed ID: 10478183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy-induced nausea and vomiting.
    Lohr L
    Cancer J; 2008; 14(2):85-93. PubMed ID: 18391612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-emetics in oncology].
    Mahjoubi M; Lopez C; Pallard MC; Droz JP
    Rev Infirm; 1990 Dec; 40(19):35-7. PubMed ID: 2091208
    [No Abstract]   [Full Text] [Related]  

  • 40. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Slabý J; Trnený M; Procházka B; Klener P
    Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.